Peer-Reviewed Original Research Articles |
| 1. | Melhem-Bertrandt A, Bojadzieva J, Ready KJ, Obeid E, Liu DD, Gutierrez-Barrera AM, Litton JK, Olopade OI, Hortobagyi GN, Strong LC, Arun BK. Early onset HER2-positive breast cancer is associated with germline TP53 mutations. Cancer 118(4):908-13, 2/2012. e-Pub 7/2011. PMID: 21761402. |
| 2. | Melhem-Bertrandt A, Sood AK. New directions in reducing stress effects on cancer. Cancer Prev Res (Phila) 5(2):147-9, 2/2012. PMID: 22307563. |
| 3. | Bayraktar S, Gonzalez-Angulo AM, Lei X, Buzdar AU, Valero V, Melhem-Bertrandt A, Kuerer HM, Hortobagyi GN, Sahin AA, Meric-Bernstam F. Efficacy of Neoadjuvant Therapy with Trastuzumab Concurrent with Anthracycline- and Non-anthracycline-based Regimens for HER2-Positive Breast Cancer. Cancer. e-Pub 9/2011. PMCID: PMC3274632. |
| 4. | Melhem-Bertrandt A, Chavez-Macgregor M, Lei X, Brown EN, Lee RT, Meric-Bernstam F, Sood AK, Conzen SD, Hortobagyi GN, Gonzalez-Angulo AM. Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer. J Clin Oncol 29(19):2645-52, 7/2011. e-Pub 5/2011. PMCID: PMC3139371. |
| 5. | Melhem-Bertrandt A, Conzen SD. The relationship between psychosocial stressors and breast cancer biology. Curr Breast Cancer Rep 2:130-137, 8/2010. e-Pub 8/2010. |
| 6. | Melhem-Bertrandt A, Hortobagyi G. Primary invasive breast cancer. BMJ Point-of-Care 2010, 2010. |
| 7. | Belova L, Delgado B, Kocherginsky M, Melhem A, Olopade OI, Conzen SD. Glucocorticoid receptor expression in breast cancer associates with older patient age. Breast Cancer Res Treat 116(3):441-7, 8/2009. e-Pub 7/2008. PMID: 18668364. |
| 8. | Melhem A, Yamada SD, Fleming GF, Delgado B, Brickley DR, Wu W, Kocherginsky M, Conzen SD. Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues. Clin Cancer Res 15(9):3196-204, 5/2009. e-Pub 4/2009. PMID: 19383827. |
| 9. | Sabloff B, Munden RF, Melhem AI, El-Naggar AK, Putnam JB. Radiologic-pathologic conferences of the University of Texas M. D. Anderson Cancer Center: Extraskeletal osteosarcoma of the pleura. Am J Roentgenol 180(4):972, 4/2003. PMID: 12646438. |
Invited Articles |
| 1. | Melhem A, Conzen R. Serum and Glucocorticoid - Regulated Protein Kinases in Disease. Review. Targeted protein Database. Current BioData. In Press. |
| Other Articles |
| 1. | Melhem-Bertrandt A. Commentary. Breast Diseases: A Year Book Quarterly. In Press. |
| 2. | Cohen E, Melhem A. ASCO 2008 Highlights in Head and Neck Cancers. Medscape Hematology-Oncology, 7/2008. |
Abstracts |
| 1. | Chavez-MacGregor M, Lei X, Litton JK, Melhem A, Mittendorf EA, Meric-Bernstam F, Sahin AA, Valero V, Hortobagyi GN, Gonzalez-Angulo AM. Predictors of recurrence among breast cancer patients who achieved a pathological complete response (pCR) after neoadjuvant systemic chemotherapy. 2011 ASCO Annual Meeting (#78031). In Press. |
| 2. | Anders CK, Nada R, Liu C, Blackwell KL, Van Poznak CH, Abramson VG, Storniolo AM, Lin NU, Stearns V, Melhem A, Puhalla S, Carpenter JT, Melisko ME, Deal AM, Hudis C, Winer EP, Perou CM, Bradley CR, Wolff AC, Carey LA. TBCRC 018: phase II study of iniparib plus chemotherapy to treat triple negative breast cancer (TNBC) brain metastases (BM). 2011 ASCO Annual Meeting (#74495). In Press. |
| 3. | Melhem-Bertrandt A, Ready KJ, Gutierrez-Barrera AM, Litton J, Strong LC, Olopade OI, Hortobagyi GN, Arun BK. Increased rate of HER2-positive breast cancers among women with germline TP53 mutations. San Antonio Breast Cancer Symposium, 12/2010. |
| 4. | Pusztai L, Moulder S, Litton J, Valero V, Ueno N, Melhem-Bertrandt A, Morrow PK, Dotter K, Mattair DN, Strauss L, Qi Y, Hortobagyi GN, Symmans WF. Prospective testing of three different gene signatures patient selection for dasatinib therapy in metastatic breast cancer. San Antonio Breast Cancer Symposium, 12/2010. |
| 5. | Melhem A, Yamada SD, Fleming G, Delgado B, Kocherginsky M, Conzen SD. Glucocorticoid administration upregulates the anti-apoptotic gene SGK in ovarian cancer patients. Proceedings of the American Association for Cancer Research, 4/2008. |
| 6. | Sabloff BS, Munden RF, Slaughter KD, Melhem A. Comparison of the visualization of normal anatomic structures using digital radiography and analog. RSNA 2001 Scientific Paper, 11/2001. |
Book Chapters |
| 1. | Melhem A, Conzen S. Connecting environmental stress to cancer cell biology through the neuroendocrine response. In: Encyclopedia of Environmental Health. 1. Ed(s) Hriagu, JO. Elsevier, 882-827, 2011. | |
| 2. | Donald A. Briscoe. In: Lange Q&A: USMLE STEP 3 (4th Edition). McGraw-Hill, 2005. | |
